Novo Nordisk (NYSE: NVO) and Hims & Hers Health (NYSE: HIMS) announced they were collaborating to allow Hims & Hers to sell ...

It’s not often that investors come across the kind of companies that can yield a multi-bagger investment over the years.

In its first-quarter 2025 investor letter, Carillon Scout Mid Cap Fund highlighted stocks such as Hims & Hers Health, Inc.

Novo Nordisk ends Wegovy deal with Hims over legal issues, sending the stock tumbling. What happens next? Here's a look.

Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, ...